Quantcast

Latest Erythropoietin Stories

2014-01-28 12:30:02

The CKD Market Will Decline Through 2017, Due to Genericization of Expensive Agents and Reimbursement Constraints in the U.S., According to Findings from Decision Resources Group BURLINGTON, Mass., Jan. 28, 2014 /PRNewswire/ -- Decision Resources Group finds that, after an initial decline driven by generic and biosimilar competition in the G7 markets and changes in reimbursement practices in the United States, the total chronic kidney disease (CKD) market will return to growth, achieving...

2014-01-07 13:47:40

In recent years, non-hematopoietic effects of erythropoietin (EPO), via its binding to the EPO receptor in non-hematopoietic tissues, including cancerous tissues, has been reported by many different laboratories worldwide. However, it remains controversial concerning whether EPO, particularly recombinant EPO that is used to treat anemia in patients, may promote cancer cell proliferation and survival. In this paper, the authors show evidence indicating the presence of autocrine/paracrine...

2013-09-24 23:31:21

MarketResearchReports.Biz announces addition of new report “Chemotherapy Induced Anemia - Pipeline Review, H2 2013” to its database. Visit http://www.marketresearchreports.biz/analysis-details/chemotherapy-induced-anemia-pipeline-review-h2-2013. Albany, NY (PRWEB) September 24, 2013 Chemotherapy Induced Anemia - Pipeline Review, H2 2013 Summary Global Markets Directs, 'Chemotherapy Induced Anemia - Pipeline Review, H2 2013', provides an overview of the indications therapeutic...

2013-09-04 23:03:51

Medical Food Designed to Address the Increased Nutritional Requirements of Anemia Los Angeles, CA (PRWEB) September 04, 2013 Targeted Medical Pharma, Inc. (OTCQB: TRGM), today announced the company has initiated a third open-label clinical trial of its oral amino acid-based erythropoietin stimulating system (ESS) to determine increased red blood cell production in subjects diagnosed with anemia of chronic disease. The study consists of 30 patients randomized for treatment across...

2013-07-18 10:27:16

In patients with high-risk breast cancer, addition of the erythropoiesis-stimulating agent (ESA) epoetin alfa to the chemotherapy regimen may help avoid the decrease in hemoglobin levels and resulting anemia often seen in these patients and does not negatively affect relapse-free (RFS) or overall survival (OS). However, it can increase the risk of thrombotic events, according to a study published July 17 in the Journal of the National Cancer Institute. To investigate the safety and...

2013-06-10 12:57:45

Researchers at Whitehead Institute have identified a protein that is the target of glucocorticoids, the drugs that are used to increase red blood cell production in patients with certain types of anemia, including those resulting from trauma, sepsis, malaria, kidney dialysis, and chemotherapy. The discovery could spur development of drugs capable of increasing this protein's production without causing the severe side effects associated with glucocorticoids. "This research is medically...


Word of the Day
siliqua
  • A Roman unit of weight, 1⁄1728 of a pound.
  • A weight of four grains used in weighing gold and precious stones; a carat.
  • In anatomy, a formation suggesting a husk or pod.
  • The lowest unit in the Roman coinage, the twenty-fourth part of a solidus.
  • A coin of base silver of the Gothic and Lombard kings of Italy.
'Siliqua' comes from a Latin word meaning 'a pod.'
Related